Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. PAYS
PAYS logo

PAYS Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
7.350
Open
7.220
VWAP
7.22
Vol
476.27K
Mkt Cap
406.43M
Low
7.030
Amount
3.44M
EV/EBITDA(TTM)
--
Total Shares
55.91M
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Paysign, Inc. is a provider of prepaid card programs, patient affordability offerings, digital banking services and integrated payment processing designed for businesses, consumers and government institutions. The Company’s payment solutions are utilized by its corporate customers to increase customer loyalty, increase patient adherence rates, reduce administration costs and streamline operations. It markets its prepaid card solutions under its Paysign brand. Its end-to-end technologies securely enable digital payout solutions and facilitate the distribution of funds for donor compensation, copay assistance, employee rewards, travel expenses, per diem, reimbursements, rebates, and countless other exchanges of value. It operates on a payments platform with fintech capabilities that can be seamlessly integrated with its clients’ systems. It offers donor engagement app, which integrates seamlessly with existing donor management systems, delivering immediate value to plasma centers.
Show More

Events Timeline

(ET)
2026-05-13
10:40:00
Paysign Sees 2026 Revenue Guidance of $106.5M-$110.5M
select
2026-05-13
10:40:00
Sees Q2 Revenue of $26.2M-$26.7M
select
2026-05-13
10:30:00
Paysign Reports Q1 Revenue of $28.04M
select
2026-05-12 (ET)
2026-05-12
19:10:00
Qualcomm Shares Drop Over 11% as Investors Worry About AI Demand
select
2026-05-12
16:40:00
Sees Revenue of $26.2M-$26.7M
select
2026-05-12
16:40:00
Paysign Sees 2026 Revenue Between $106.5M and $110.5M
select
2026-05-12
16:30:00
Paysign Q1 Revenue $28.04M, Exceeds Consensus
select

News

Fool
9.5
05-13Fool
Paysign Reports Strong Q1 Growth but Conservative Guidance Leads to Stock Drop
  • Significant Earnings Growth: Paysign's Q1 revenue surged 50.8% to $28.04 million, with adjusted EPS rising 80% to $0.09, both figures significantly exceeding analyst expectations, showcasing the company's robust performance in payment card processing.
  • Pharmaceutical Business Expansion: The pharmaceutical segment grew by 81.9%, adding 45 patient affordability programs and achieving a 50% increase in customer count, indicating Paysign's enhanced market penetration in the pharmaceutical sector and bolstering future revenue potential.
  • Plasma Donation Revenue Recovery: Plasma donation revenue increased by 24.9%, with a rise in customer numbers and revenue per donor center rebounding for the first time after a downturn, suggesting a recovery in business performance after a challenging period.
  • Negative Market Reaction: Despite strong results, management's decision to maintain guidance without raising expectations led to a stock price decline after a 35% year-to-date increase, reflecting investor caution regarding future growth prospects.
seekingalpha
9.5
05-13seekingalpha
Paysign Reports Strong Q1 2026 Earnings with Pharma Growth
  • Significant Revenue Growth: Paysign reported Q1 2026 revenue of $28 million, a 50.8% increase year-over-year, with net income rising 110% to $5.4 million, highlighting strong demand in the patient affordability sector and robust market performance.
  • Program Expansion: The company launched four new programs in Q1, bringing total active programs to 135, with expectations to reach 147 to 150 by the end of Q2, indicating a proactive strategy to expand market share and client base.
  • Margin Improvement: Gross profit margin increased from 62.9% to 65%, primarily due to a higher revenue mix from pharma, while operating margin rose from 13.4% to 23.8%, demonstrating significant improvements in cost control and profitability.
  • Optimistic Outlook: Management expects full-year revenue between $106.5 million and $110.5 million, with net income projected at $13 million to $16 million, reflecting confidence in achieving the upper end of guidance based on a strong start to the year.
Fool
9.5
05-13Fool
Wix.com Leverages AI Tools to Achieve Revenue Growth
  • Significant Revenue Growth: Wix.com reported a 14% year-over-year increase in first-quarter revenue to $541 million, exceeding market expectations and demonstrating resilience amid AI competition, with management forecasting mid-teens growth in revenue and bookings for 2026.
  • Share Buyback Strategy: The company repurchased approximately 30% of its outstanding shares in April to counteract a stock price decline of over 10% following the earnings update, indicating management's confidence in the company's long-term value.
  • Accelerated AI Innovation: Wix.com recently launched its proprietary LLM, powering its website editor Wix Harmony, showcasing the company's enhanced innovation capabilities in the AI-driven web and app building space.
  • Intensifying Market Competition: Despite challenges from AI competitors like Anthropic's Claude Design, Wix.com is striving to maintain market share, with the CEO emphasizing the company's adaptability in a rapidly changing technological landscape.
seekingalpha
9.5
05-12seekingalpha
Paysign Set to Announce Q1 Earnings with Strong Estimates
  • Earnings Announcement: Paysign (PAYS) is set to release its Q1 earnings on May 12th after market close, with consensus EPS estimate at $0.07 and revenue estimate at $27.01 million, reflecting a robust 45.2% year-over-year growth.
  • Performance Beat: Over the past year, Paysign has exceeded EPS estimates 75% of the time and revenue estimates 100% of the time, indicating a strong track record of reliability and profitability that could bolster investor confidence.
  • Estimate Revisions: In the last three months, EPS estimates have seen three upward revisions with no downward adjustments, while revenue estimates have experienced four upward revisions, suggesting increasing analyst confidence in the company's future performance, which may drive stock price appreciation.
  • Long-term Growth Target: Paysign has outlined a revenue growth target of 30%-35% for 2026 with ongoing margin expansion, reflecting the company's strategic positioning to capitalize on future market opportunities and providing a positive outlook for investors.
Newsfilter
9.5
04-15Newsfilter
Paysign to Discuss Q1 2026 Earnings on May 12
  • Earnings Call Schedule: Paysign, Inc. will discuss its Q1 2026 earnings on May 12, 2026, at 5:00 p.m. Eastern Time, which is expected to provide crucial insights into the company's financial performance that may influence investor decisions.
  • Participant Details: U.S. dial-in number is 877.407.2988, and international dial-in is +1.201.389.0923, offering multiple participation options to ensure investors can conveniently access the information.
  • Replay Information: The earnings call replay will be available until August 12, 2026, with dial-in numbers 877.660.6853 or +1.201.612.7415, ensuring that investors who cannot participate live can still obtain relevant information.
  • Company Overview: Paysign focuses on the intersection of fintech and healthcare, providing patient affordability solutions and donor compensation programs, committed to improving efficiencies, reducing costs, and optimizing payment processing in the life sciences sector.
NASDAQ.COM
8.0
03-25NASDAQ.COM
Surge in Options Trading Volume for Paysign and ASTS
  • Options Volume Surge for Paysign: Today, Paysign Inc's options volume reached 4,544 contracts, equivalent to approximately 454,400 shares, representing 89% of its average daily trading volume of 510,355 shares over the past month, indicating strong investor interest in the stock.
  • High-Frequency Trading Insight: Notably, the $5 strike call option expiring on April 17, 2026, saw 2,713 contracts traded today, representing about 271,300 shares, suggesting market expectations for future price increases.
  • ASTS Options Activity: Concurrently, AST SpaceMobile Inc recorded options trading volume of 114,469 contracts, approximately 11.4 million shares, which is 88.9% of its average daily trading volume of 12.9 million shares over the past month, reflecting sustained market interest in the company.
  • Bullish Call Options Trend: Particularly, the $95 strike call option expiring on April 2, 2026, had 7,468 contracts traded today, representing around 746,800 shares, indicating optimistic sentiment among investors regarding ASTS's future performance.
Wall Street analysts forecast PAYS stock price to rise
4 Analyst Rating
Wall Street analysts forecast PAYS stock price to rise
4 Buy
0 Hold
0 Sell
Strong Buy
Current: 0.000
sliders
Low
8.50
Averages
9.00
High
10.00
Current: 0.000
sliders
Low
8.50
Averages
9.00
High
10.00
Lake Street
Jacob Stephan
Buy
maintain
$10 -> $11
AI Analysis
2026-03-25
Reason
Lake Street
Jacob Stephan
Price Target
$10 -> $11
AI Analysis
2026-03-25
maintain
Buy
Reason
Lake Street analyst Jacob Stephan raised the firm's price target on Paysign to $11 from $10 and keeps a Buy rating on the shares. The firm, which is raising estimates, believes Paysign's "fundamental inflection is still in the early innings," the analyst tells investors after a Q4 beat and "strong" 2026 guidance.
Lake Street
Jacob Stephan
Buy
maintain
$9 -> $10
2025-08-06
Reason
Lake Street
Jacob Stephan
Price Target
$9 -> $10
2025-08-06
maintain
Buy
Reason
Lake Street analyst Jacob Stephan raised the firm's price target on Paysign to $10 from $9 and keeps a Buy rating on the shares after the company reported a beat and raise quarter. Paysign is "in the early innings of an inflection in pharma revenues," according to the analyst, who believes "investors should take note."
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for PAYS
Unlock Now

Valuation Metrics

The current forward P/E ratio for Paysign Inc (PAYS.O) is 29.59, compared to its 5-year average forward P/E of 0.14. For a more detailed relative valuation and DCF analysis to assess Paysign Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
0.14
Current PE
29.59
Overvalued PE
291.69
Undervalued PE
-291.41

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
19.06
Current EV/EBITDA
9.85
Overvalued EV/EBITDA
27.55
Undervalued EV/EBITDA
10.58

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
3.02
Current PS
3.18
Overvalued PS
3.85
Undervalued PS
2.20

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

what $5-10 stocks are surging on Tuesday
Intellectia · 88 candidates
Price: $5.00 - $10.00Price Change Pct: >= $5.00List Exchange: XNYS, XNAS, XASE
Ticker
Name
Market Cap$
top bottom
MTC logo
MTC
MMTEC Inc
718.03M
SKIL logo
SKIL
Skillsoft Corp
47.76M
ROLR logo
ROLR
High Roller Technologies Inc
55.43M
RVYL logo
RVYL
Ryvyl Inc
6.30M
BYRN logo
BYRN
Byrna Technologies Inc
148.36M
OSS logo
OSS
One Stop Systems Inc
219.17M
most bullish industry tomorrow
Intellectia · 48 candidates
Moving Average Relationship: PriceAboveMA20Option Sentiments: BullishOne Day Rise Prob: >= 65One Day Predict Return: >= 1.5%Monthly Average Dollar Volume: >= 300,000
Ticker
Name
Market Cap$
top bottom
NMG logo
NMG
Nouveau Monde Graphite Inc
348.99M
EXLS logo
EXLS
Exlservice Holdings Inc
4.81B
PLMR logo
PLMR
Palomar Holdings Inc
3.34B
ST logo
ST
Sensata Technologies Holding PLC
5.10B
MPAA logo
MPAA
Motorcar Parts of America Inc
204.21M
HDSN logo
HDSN
Hudson Technologies Inc
248.87M
high risk high reward stocks
Intellectia · 25 candidates
Market Cap: 100.00M - 5.00BPrice: $2.00 - $50.00Quarter Revenue Yoy Growth: >= 25.0%Beta: HighRiskQuarter Price Change Pct: >= $15.00
Ticker
Name
Market Cap$
top bottom
TYGO logo
TYGO
Tigo Energy Inc
266.27M
LWLG logo
LWLG
Lightwave Logic Inc
1.22B
PRLD logo
PRLD
Prelude Therapeutics Inc
277.21M
DAWN logo
DAWN
Day One Biopharmaceuticals Inc
2.22B
ATOM logo
ATOM
Atomera Inc
157.60M
AMPX logo
AMPX
Amprius Technologies Inc
2.29B
Best low priced stock to buy
Intellectia · 48 candidates
Region: USPrice: $2.00 - $15.00Eps Ttm: >= 0List Exchange: XNYS, XNAS, XASEMonth Price Change Pct: $5.00 - $100.00Monthly Average Dollar Volume: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
ALTO logo
ALTO
Alto Ingredients Inc
354.78M
LCUT logo
LCUT
Lifetime Brands Inc
120.52M
PAYS logo
PAYS
Paysign Inc
317.87M
CCLD logo
CCLD
CareCloud Inc
149.58M
JVA logo
JVA
Coffee Holding Co Inc
24.49M
IDN logo
IDN
Intellicheck Inc
129.93M
What stock can I profit day trading $46
Intellectia · 8 candidates
Region: USPrice: $2.00 - $10.00Price Change Pct: $3.00 - $15.00Relative Vol: >= 1.50Beta: HighRiskList Exchange: XNYS, XNAS, XASEMonthly Average Dollar Volume: >= 2,000,000
Ticker
Name
Market Cap$
top bottom
MARA logo
MARA
MARA Holdings Inc
3.26B
HTZ logo
HTZ
Hertz Global Holdings Inc
1.49B
KPTI logo
KPTI
Karyopharm Therapeutics Inc
109.27M
AVXL logo
AVXL
Anavex Life Sciences Corp
266.89M
PAYS logo
PAYS
Paysign Inc
294.14M
MBOT logo
MBOT
Microbot Medical Inc
175.95M
high volume low float stocks today
Intellectia · 31 candidates
Market Cap: 50.00M - 5.00BRegion: USPrice: $1.00 - $50.00Volume: >= 1,000,000Relative Vol: >= 2Floating Shares: <= 30,000,000
Ticker
Name
Market Cap$
top bottom
BATL logo
BATL
Battalion Oil Corp
95.48M
PAYS logo
PAYS
Paysign Inc
283.70M
FUBO logo
FUBO
FuboTV Inc
1.18B
SLND logo
SLND
Southland Holdings Inc
71.43M
KSCP logo
KSCP
Knightscope Inc
77.31M
AGRO logo
AGRO
Adecoagro SA
2.10B
high volume low float stocks
Intellectia · 69 candidates
Region: USVolume: >= 1,000,000Floating Shares: <= 30,000,000
Ticker
Name
Market Cap$
top bottom
PAVS logo
PAVS
Paranovus Entertainment Technology Ltd
1.28M
HKIT logo
HKIT
Hitek Global Inc
2.10M
WNW logo
WNW
Meiwu Technology Co Ltd
2.04M
ASNS logo
ASNS
Actelis Networks Inc
10.05M
UGRO logo
UGRO
urban-gro Inc
5.28M
RAYA logo
RAYA
Erayak Power Solution Group Inc
370.63K
best penny stock to invest in
Intellectia · 28 candidates
Market Cap: 50.00M - 2.00BPrice: $0.50 - $5.00Quarter Revenue Yoy Growth: >= 10.0%Net Margin: >= 0.01List Exchange: XNYS, XNAS, XASEMonthly Average Dollar Volume: >= 500,000
Ticker
Name
Market Cap$
top bottom
BTCS logo
BTCS
BTCS Inc
74.02M
CPSH logo
CPSH
CPS Technologies Corp
84.14M
NIU logo
NIU
NIU Technologies
262.74M
AKBA logo
AKBA
Akebia Therapeutics Inc
313.13M
OGI logo
OGI
Organigram Global Inc
186.49M
PAYS logo
PAYS
Paysign Inc
179.99M
whats the best penny stocks to invest into
Intellectia · 25 candidates
Market Cap: <= 1000.00MPrice: <= $5.00Eps Ttm: >= 0Weekly Average Turnover: >= 1,000,000Annual Revenue Yoy Growth: >= 10.0%
Ticker
Name
Market Cap$
top bottom
CRON logo
CRON
Cronos Group Inc
999.35M
GOGO logo
GOGO
Gogo Inc
642.50M
TALK logo
TALK
Talkspace Inc
632.81M
DDL logo
DDL
Dingdong (Cayman) Ltd
602.62M
NPWR logo
NPWR
NET Power Inc
575.35M
VTEX logo
VTEX
VTEX
573.92M
good penny stocks to invest in
Intellectia · 32 candidates
Market Cap: <= 500.00MPrice: <= $5.00Quarter Revenue Yoy Growth: >= 10.0%Beta: HighRiskWeekly Average Turnover: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
CAN logo
CAN
Canaan Inc
498.64M
ORGO logo
ORGO
Organogenesis Holdings Inc
487.34M
CERS logo
CERS
Cerus Corp
485.98M
OCGN logo
OCGN
Ocugen Inc
465.36M
API logo
API
Agora Inc
402.42M
NNDM logo
NNDM
Nano Dimension Ltd
395.43M

Whales Holding PAYS

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Paysign Inc (PAYS) stock price today?

The current price of PAYS is 7.27 USD — it has increased 1.11

What is Paysign Inc (PAYS)'s business?

Paysign, Inc. is a provider of prepaid card programs, patient affordability offerings, digital banking services and integrated payment processing designed for businesses, consumers and government institutions. The Company’s payment solutions are utilized by its corporate customers to increase customer loyalty, increase patient adherence rates, reduce administration costs and streamline operations. It markets its prepaid card solutions under its Paysign brand. Its end-to-end technologies securely enable digital payout solutions and facilitate the distribution of funds for donor compensation, copay assistance, employee rewards, travel expenses, per diem, reimbursements, rebates, and countless other exchanges of value. It operates on a payments platform with fintech capabilities that can be seamlessly integrated with its clients’ systems. It offers donor engagement app, which integrates seamlessly with existing donor management systems, delivering immediate value to plasma centers.

What is the price predicton of PAYS Stock?

Wall Street analysts forecast PAYS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PAYS is9.00 USD with a low forecast of 8.50 USD and a high forecast of 10.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Paysign Inc (PAYS)'s revenue for the last quarter?

Paysign Inc revenue for the last quarter amounts to 28.04M USD, increased 50.76

What is Paysign Inc (PAYS)'s earnings per share (EPS) for the last quarter?

Paysign Inc. EPS for the last quarter amounts to 0.09 USD, increased 80.00

How many employees does Paysign Inc (PAYS). have?

Paysign Inc (PAYS) has 226 emplpoyees as of June 01 2026.

What is Paysign Inc (PAYS) market cap?

Today PAYS has the market capitalization of 406.43M USD.